A Phase 2 random, double-blind, placebo-controlled study of the safety and immunogenicity of a recombinant G protein-based respiratory syncytial virus vaccine in healthy older adults
Lunan Zhang, Gan Zhao, Xin Cheng, Shuo Wang, Jiarong Wang, Xuefen Huai, Yu Xia, Yanling Xiao, Sulin Ren, Shijie Zhang, Bin Wang
doi: https://doi.org/10.1101/2023.10.26.23297584
